CAMPHOR

N/A

Manufactured by Strides Consumer LLC

1,159 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CAMPHOR

CAMPHOR is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Strides Consumer LLC. The most commonly reported adverse reactions for CAMPHOR include FATIGUE, PAIN, DRUG HYPERSENSITIVITY, PRURITUS, DYSPNOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CAMPHOR.

Top Adverse Reactions

FATIGUE30 reports
PAIN30 reports
DRUG HYPERSENSITIVITY29 reports
PRURITUS26 reports
DYSPNOEA25 reports
ERYTHEMA25 reports
HEADACHE24 reports
PNEUMONIA24 reports
COUGH23 reports
INSOMNIA23 reports
SINUSITIS23 reports
URTICARIA23 reports
INFECTION22 reports
INFLUENZA22 reports
MIGRAINE22 reports
MYALGIA22 reports
NASOPHARYNGITIS22 reports
OROPHARYNGEAL PAIN22 reports
STRESS22 reports
BACK PAIN21 reports
CHILLS21 reports
DIZZINESS POSTURAL21 reports
NASAL CONGESTION21 reports
ASTHMA20 reports
ILLNESS20 reports
NAUSEA20 reports
NERVOUSNESS20 reports
PIGMENTATION DISORDER20 reports
RHINORRHOEA20 reports
SCRATCH20 reports
SECRETION DISCHARGE20 reports
SKIN PLAQUE20 reports
URTICARIA THERMAL20 reports
VITAMIN B12 DEFICIENCY20 reports
ADMINISTRATION SITE ERYTHEMA14 reports
DRUG INEFFECTIVE14 reports
HAEMATOMA14 reports
INJECTION SITE BRUISING14 reports
INJECTION SITE REACTION14 reports
THERAPEUTIC PRODUCT EFFECT DECREASED14 reports
FALL13 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION13 reports
VOMITING12 reports
OFF LABEL USE11 reports
HYPOTENSION9 reports
PYREXIA9 reports
ANXIETY8 reports
RENAL FAILURE8 reports
SEDATION8 reports
ANTICHOLINERGIC SYNDROME7 reports
DIZZINESS7 reports
CHRONIC KIDNEY DISEASE6 reports
HALLUCINATION, VISUAL6 reports
PAIN IN EXTREMITY6 reports
ABDOMINAL PAIN5 reports
ACUTE KIDNEY INJURY5 reports
ALOPECIA5 reports
APNOEA5 reports
ASTHENIA5 reports
BRADYCARDIA5 reports
CONSTIPATION5 reports
HALLUCINATION5 reports
HYPOTHERMIA5 reports
LARGE INTESTINAL OBSTRUCTION5 reports
LYMPHADENOPATHY5 reports
MENTAL STATUS CHANGES5 reports
OEDEMA PERIPHERAL5 reports
SMALL INTESTINAL PERFORATION5 reports
SOMNOLENCE5 reports
TOXICITY TO VARIOUS AGENTS5 reports
AGITATION4 reports
ALTERED STATE OF CONSCIOUSNESS4 reports
ANAEMIA4 reports
ARTHRALGIA4 reports
COMA4 reports
DEATH4 reports
DEPRESSION4 reports
DIARRHOEA4 reports
DRY SKIN4 reports
DYSGEUSIA4 reports
FLATULENCE4 reports
HYPERSENSITIVITY4 reports
MALAISE4 reports
MIOSIS4 reports
MUSCLE SPASMS4 reports
PALPITATIONS4 reports
RASH4 reports
UPPER RESPIRATORY TRACT INFECTION4 reports
VISUAL IMPAIRMENT4 reports
ACCIDENTAL EXPOSURE TO PRODUCT3 reports
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD3 reports
ACCIDENTAL OVERDOSE3 reports
BLOOD GLUCOSE INCREASED3 reports
CELLULITIS3 reports
CEREBROVASCULAR ACCIDENT3 reports
COLITIS3 reports
COMPLETED SUICIDE3 reports
DECREASED APPETITE3 reports
DEHYDRATION3 reports
DISCOMFORT3 reports

Report Outcomes

Out of 170 classified reports for CAMPHOR:

Serious 82.9%Non-Serious 17.1%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female98 (62.8%)
Male58 (37.2%)

Reports by Age

Age 6623 reports
Age 6012 reports
Age 496 reports
Age 555 reports
Age 625 reports
Age 845 reports
Age 614 reports
Age 143 reports
Age 223 reports
Age 593 reports
Age 643 reports
Age 693 reports
Age 703 reports
Age 723 reports
Age 152 reports
Age 312 reports
Age 482 reports
Age 542 reports
Age 572 reports
Age 652 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CAMPHOR?

This profile reflects 1,159 FDA FAERS reports that mention CAMPHOR. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CAMPHOR?

Frequently reported terms in FAERS include FATIGUE, PAIN, DRUG HYPERSENSITIVITY, PRURITUS, DYSPNOEA, ERYTHEMA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CAMPHOR?

Labeling and FAERS entries often list Strides Consumer LLC in connection with CAMPHOR. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.